Search Browse Earnings

NovaBridge Biosciences

Nasdaq:NBP

Pharmaceutical Preparations·ROCKVILLE, MD

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$13.8M

-94.2% YoY

FY 2021

Adj. EBITDA

-$52.9M

-382.8% margin

FY 2024

Net Income

-$371.1M

-2686.3% margin

FY 2024

EPS (Diluted)

-$1.96

FY 2024

Stock Price

$2.86

-2.7%

2026-03-16

52W Range

$0.59 – $6.79

P/E Ratio

-1.5x

Market Cap

$536.1M

Cash

$342.9M

FY 2024

Total Debt

$4.2M

FY 2023

Net Cash

$338.7M

FY 2023

Enterprise Value

$197.4M

Debt / EBITDA

6.4x

FY 2021

EV / EBITDA

-3.7x

Employees

—